HomeZNTL • NASDAQ
add
Zentalis Pharmaceuticals Inc
Previous close
$1.40
Day range
$1.34 - $1.45
Year range
$1.01 - $3.33
Market cap
99.71M USD
Avg Volume
572.63K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Revenue | — | — |
Operating expense | 33.73M | -34.41% |
Net income | -26.69M | 33.54% |
Net profit margin | — | — |
Earnings per share | -0.37 | 33.93% |
EBITDA | -33.57M | 34.31% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 280.70M | -28.26% |
Total assets | 327.25M | -27.38% |
Total liabilities | 74.38M | -22.79% |
Total equity | 252.87M | — |
Shares outstanding | 72.25M | — |
Price to book | 0.40 | — |
Return on assets | -24.84% | — |
Return on capital | -27.69% | — |
Cash Flow
Net change in cash
| (USD) | Sep 2025info | Y/Y change |
|---|---|---|
Net income | -26.69M | 33.54% |
Cash from operations | -26.96M | 38.78% |
Cash from investing | 28.32M | -41.30% |
Cash from financing | 115.00K | 25.00% |
Net change in cash | 1.47M | -65.66% |
Free cash flow | -17.51M | 39.95% |
About
Founded
2014
Website
Employees
166
